The ESTIV Members Area
Become member of ESTIV
European Society of Toxicology In Vitro > News > ESTIV and EUSAAT signed a Memorandum of Understanding
1 October 2022

ESTIV and EUSAAT signed a Memorandum of Understanding

The European Society of Toxicology in Vitro (ESTIV) and the European Society for Alternatives to Animal Testing EUSAAT signed a Memorandum of Understanding at the EUSAAT 2022 congress in Linz. The MoU aims to intensify collaboration between the two EU societies with a focus on the implementation of 3Rs and New Approach Methodologies (NAMs) into modern science, research and regulations. More information on the collaboration between the two societies will be announced at the ESTIV 2022 Congress in Barcelona-Sitges.

Related content

Special Issue completed – ESTIV 2024: The Application of New Approach Methodologies (NAMs) in Drug Discovery and Drug and Chemical Safety Assessment
  • News

ESTIV would like to extend its heartfelt thanks to all contributors to this special issue, which highlights some of the science and activities that took place during the congress.

ESTIV 2026 LAST-MINUTE ABSTRACT SUBMISSION OPEN

We are pleased to announce that last‑minute poster abstract submissions are now open.

Researchers who still wish to contribute are warmly invited to submit their work. The deadline for last‑minute submissions is 8 May 2026 at 23:59 CET.

ESTIV-ASCCT:  Award Winners Series: AI & Machine Learning

Check out the details on the next installment of our ESTIV – ASCCT Award Winners Webinar and make sure to register if you haven’t already. We hope to see you there!

Silver Sponsor

React4Life

Corporate Members
Mattek in Vitro Life Science Laboratories

Communication partners

Memorandum of Understanding